Events7th International Electronic Conference on Medicinal Chemistry
Published
This submission belongs to the session S3. General of the event 7th International Electronic Conference on Medicinal Chemistry
Published date
03 Nov, 2021
Academic Editor
author-avatarJean Jacques Vanden Eynde
Citation
Gabriele Carullo, Sarah Mazzotta, Amer Ahmed, Alfonso Trezza, Ottavia Spiga, Simona Saponara, Fabio Fusi, Francesca Aiello, Sclareolide-based small molecules, TRPV4/CaV1.2 modulators, as new vasodilating agents, in Proceedings of 7th International Electronic Conference on Medicinal Chemistry, 1 November–30 November 2021, MDPI: Basel, Switzerland, doi: 10.3390/ECMC2021-11579
Share
Email
Facebook
Twitter
LinkedIn

Sclareolide-based small molecules, TRPV4/CaV1.2 modulators, as new vasodilating agents

image
image
image
image
1. University of Siena, Italy
2. Department of Pharmaceutical Sciences, University of Milan, Via Luigi Mangiagalli 20125, Milan, Italy.
3. Department of Life Sciences, University of Siena, Via Aldo Moro 2, 53100 Siena, Italy.
4. Department of Biotechnology, Chemistry and Pharmacy, University of Siena, Via Aldo Moro 2, 53100 Siena, Italy.
5. Department of Pharmacy, Health and Nutritional Sciences, University of Calabria, Edificio Polifunzionale, 87036 Arcavacata di Rende (CS), Italy
Abstract

Sclareolide is a fragrant sesquiterpene lactone found in Salvia sclarea, used as flavor additive in food. (+)-Sclareolide gained attention due to its versatility, since its lactone ring condensed with a trans-decalin-related homodrimane core can be easily opened and functionalized. Structural similarity between sclareolide and phorbol derivatives or onydecalin A, known TRPV4 modulators, prompted us to evaluate if sclareolide and its derivatives could modulate the activity of this channel. A small but diversified library of derivatives, characterized by the homodrimane backbone bearing flexible tails of different nature and chemical properties at position 1, was synthesized. In particular, the substituent groups, bound to the bicyclic nucleus by either an amide or ester or ether functionality, differ in size, flexibility, and electronic properties. The most interesting compounds were active in the submicromolar range and belong to the homodrimanyl acid amide series, in particular, benzyl and phenylethyl amides. Considering that inappropriate activation of TRPV4 produces acute circulatory collapse associated with endothelial activation/injury, and considering that the role of TRPV4 is confused, we investigated the best performing compounds as vasodilators in rat myocytes. The compounds were able to reduce the currents associated with IBa1.2; the mechanism of the interaction between the most intriguing compound and CaV1.2 channel was voltage-dependent and antagonized by a channel activator such as Bay K 8644. Furthermore, this compound stabilizes the inactivated state of the channel. Finally, it inhibits the contraction of the aorta rings induced by high potassium with an IC50 comparable to that obtained on the channels.

Keywords
sclareolide
TRPV4
CaV1.2
vasodilation.
Poster
Gabriele Carullo.pdf
Investigation of CA-4 metabolism and related β-lactam analogues in chemoresistant HT-29 colon cancer cells
Phytochemicals and elucidation of polyphenol compounds of aqueous-methanol fraction of Desmodium velutinum stem using high performance liquid chromatography